Laukkanen, L.; Diniz, C.R.A.F.; Foulquier, S.; Prickaerts, J.; Castrén, E.; Casarotto, P.C.
Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21. Pharmaceuticals 2021, 14, 773.
https://doi.org/10.3390/ph14080773
AMA Style
Laukkanen L, Diniz CRAF, Foulquier S, Prickaerts J, Castrén E, Casarotto PC.
Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21. Pharmaceuticals. 2021; 14(8):773.
https://doi.org/10.3390/ph14080773
Chicago/Turabian Style
Laukkanen, Liina, Cassiano R. A. F. Diniz, Sebastien Foulquier, Jos Prickaerts, Eero Castrén, and Plinio C. Casarotto.
2021. "Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21" Pharmaceuticals 14, no. 8: 773.
https://doi.org/10.3390/ph14080773
APA Style
Laukkanen, L., Diniz, C. R. A. F., Foulquier, S., Prickaerts, J., Castrén, E., & Casarotto, P. C.
(2021). Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21. Pharmaceuticals, 14(8), 773.
https://doi.org/10.3390/ph14080773